Trial Profile
PHASE II CLINICAL EVALUATION OF PYRAZOLOACRIDINE [PD 115934] IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CARCINOMA.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Aug 2012
Price :
$35
*
At a glance
- Drugs PD 115934 (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 12 Mar 2012 Actual patient number (20) added as reported by ClinicalTrials.gov.
- 12 Mar 2012 Actual end date (February 2008) added as reported by ClinicalTrials.gov.
- 16 Oct 2005 New trial record.